BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1268974)

  • 1. [Myocardial infarct in young women and steroid contraception].
    Presl
    Cesk Gynekol; 1976 Apr; 41(2):156. PubMed ID: 1268974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Profile of cardiovascular risk factors in females with a definitive myocardial infarct up to 49 years of age].
    Stammberger K; Schneider G
    Z Gesamte Inn Med; 1989 Mar; 44(6):177-9. PubMed ID: 2728560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of hormonal contraceptives for coronary heart disease].
    Gohlke-Bärwolf C
    Herz; 1987 Aug; 12(4):263-75. PubMed ID: 3308662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myocardial infarction and oral contraceptives].
    Bounhoure JP; Galinier M; Roncalli J; Assoun B; Puel J
    Bull Acad Natl Med; 2008 Mar; 192(3):569-79; discussion 579. PubMed ID: 18819701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Myocardial infarction and estrogen therapy in premenopausal women.
    Rosenberg L; Armstrong B; Jick H
    N Engl J Med; 1976 Jun; 294(23):1290-1. PubMed ID: 1264157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of age, smoking habits, and oral contraceptives in the frequency of myocardial infarction in young women (author's transl)].
    Goldzieher JW
    Reproduccion; 1980; 4(1):21-7. PubMed ID: 7389993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of oral contraceptives: a review.
    Stubblefield PG
    Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk of oral contraceptives. Low, and mainly in women at risk.
    Prescrire Int; 1998 Aug; 7(36):118-24. PubMed ID: 10342951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arteriosclerosis risk. The roles of oral contraceptives and postmenopausal estrogens.
    Knopp RH
    J Reprod Med; 1986 Sep; 31(9 Suppl):913-21. PubMed ID: 3772911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
    Tanis BC; Rosendaal FR
    Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined contraceptives and cardiovascular risk].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial complications of estrogen-progestogen contraception].
    Jaillard J
    Ann Med Interne (Paris); 1983; 134(5):416-20. PubMed ID: 6651062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and cardiovascular disease (second of two parts).
    Stadel BV
    N Engl J Med; 1981 Sep; 305(12):672-7. PubMed ID: 7022211
    [No Abstract]   [Full Text] [Related]  

  • 19. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and myocardial infarction: new evidence leaves unanswered questions.
    Thorogood M
    Thromb Haemost; 1997 Jul; 78(1):334-8. PubMed ID: 9198175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.